# Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section

> **NCT00694343** · PHASE4 · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 167 (actual)

## Conditions studied

- Hypotension

## Interventions

- **DRUG:** HES 130/0.4 (6%) in sodium chloride (solution for infusion)
- **DRUG:** Ringer's Lactate solution

## Key facts

- **NCT ID:** NCT00694343
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2012-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694343, "Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00694343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*